Studies have shown normalization of prolactin levels in approximately 70–80% of patients; tumor size reduction was documented in about 60% of patients, with the resolution of galactorrhea, amenorrhea, infertility, and sexual function in more than half of patients [3,11]. The gene discussed is PRL; the disease is amenorrhea.